243 related articles for article (PubMed ID: 29168006)
1. Breast lesions classified as probably benign (BI-RADS 3) on magnetic resonance imaging: a systematic review and meta-analysis.
Spick C; Bickel H; Polanec SH; Baltzer PA
Eur Radiol; 2018 May; 28(5):1919-1928. PubMed ID: 29168006
[TBL] [Abstract][Full Text] [Related]
2. Frequency of Malignancy and Imaging Characteristics of Probably Benign Lesions Seen at Breast MRI.
Grimm LJ; Anderson AL; Baker JA; Johnson KS; Walsh R; Yoon SC; Ghate SV
AJR Am J Roentgenol; 2015 Aug; 205(2):442-7. PubMed ID: 26204298
[TBL] [Abstract][Full Text] [Related]
3. MR Imaging for Diagnosis of Malignancy in Mammographic Microcalcifications: A Systematic Review and Meta-Analysis.
Bennani-Baiti B; Baltzer PA
Radiology; 2017 Jun; 283(3):692-701. PubMed ID: 27788035
[TBL] [Abstract][Full Text] [Related]
4. Follow-up results of BI-RADS 3 lesions on magnetic resonance imaging: a retrospective study.
Aslan Ö; Oktay A; Eroğlu F
Diagn Interv Radiol; 2024 May; 30(3):175-182. PubMed ID: 38293846
[TBL] [Abstract][Full Text] [Related]
5. BI-RADS category 3, 4, and 5 lesions identified at preoperative breast MRI in patients with breast cancer: implications for management.
Lee SE; Lee JH; Han K; Kim EK; Kim MJ; Moon HJ; Yoon JH; Park VY
Eur Radiol; 2020 May; 30(5):2773-2781. PubMed ID: 32006168
[TBL] [Abstract][Full Text] [Related]
6. Characteristics and Outcomes of BI-RADS 3 Lesions on Breast MRI.
Panigrahi B; Harvey SC; Mullen LA; Falomo E; Di Carlo P; Lee B; Myers KS
Clin Breast Cancer; 2019 Feb; 19(1):e152-e159. PubMed ID: 30268764
[TBL] [Abstract][Full Text] [Related]
7. Rate of malignancy in MRI-detected probably benign (BI-RADS 3) lesions.
Spick C; Szolar DH; Baltzer PA; Tillich M; Reittner P; Preidler KW; Pinker-Domenig K; Helbich TH
AJR Am J Roentgenol; 2014 Mar; 202(3):684-9. PubMed ID: 24555608
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic utility of second-look US for breast lesions identified at MR imaging: systematic review and meta-analysis.
Spick C; Baltzer PA
Radiology; 2014 Nov; 273(2):401-9. PubMed ID: 25119022
[TBL] [Abstract][Full Text] [Related]
9. Benign (BI-RADS 2) lesions in breast MRI.
Spick C; Szolar DH; Tillich M; Reittner P; Preidler KW; Baltzer PA
Clin Radiol; 2015 Apr; 70(4):395-9. PubMed ID: 25649442
[TBL] [Abstract][Full Text] [Related]
10. MR imaging in probably benign lesions (BI-RADS category 3) of the breast.
Gökalp G; Topal U
Eur J Radiol; 2006 Mar; 57(3):436-44. PubMed ID: 16316732
[TBL] [Abstract][Full Text] [Related]
11. Management for BI-RADS category 3 lesions detected in preoperative breast MR imaging of breast cancer patients.
Gweon HM; Cho N; Kim SY; Koo HR; Seo M; Chu A; Son EJ
Eur Radiol; 2017 Aug; 27(8):3211-3216. PubMed ID: 28083693
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of probably benign breast MRI lesions.
Eby PR; DeMartini WB; Gutierrez RL; Saini MH; Peacock S; Lehman CD
AJR Am J Roentgenol; 2009 Sep; 193(3):861-7. PubMed ID: 19696303
[TBL] [Abstract][Full Text] [Related]
13. Subclassification of BI-RADS 4 Magnetic Resonance Lesions: A Systematic Review and Meta-Analysis.
Li J; Zheng H; Cai W; Wang Y; Zhang H; Liao M
J Comput Assist Tomogr; 2020; 44(6):914-920. PubMed ID: 33196599
[TBL] [Abstract][Full Text] [Related]
14. BI-RADS lesion characteristics predict likelihood of malignancy in breast MRI for masses but not for nonmasslike enhancement.
Gutierrez RL; DeMartini WB; Eby PR; Kurland BF; Peacock S; Lehman CD
AJR Am J Roentgenol; 2009 Oct; 193(4):994-1000. PubMed ID: 19770321
[TBL] [Abstract][Full Text] [Related]
15. Probably benign breast MRI lesions: frequency, lesion type, and rate of malignancy.
Lourenco AP; Chung MT; Mainiero MB
J Magn Reson Imaging; 2014 Apr; 39(4):789-94. PubMed ID: 24108546
[TBL] [Abstract][Full Text] [Related]
16. BI-RADS® 3 lesions at contrast-enhanced breast MRI: is an initial short-interval follow-up necessary?
Bahrs SD; Baur A; Hattermann V; Hahn M; Vogel U; Claussen CD; Siegmann-Luz KC
Acta Radiol; 2014 Apr; 55(3):260-5. PubMed ID: 23969262
[TBL] [Abstract][Full Text] [Related]
17. Probably benign lesions at screening breast US in a population with elevated risk: prevalence and rate of malignancy in the ACRIN 6666 trial.
Barr RG; Zhang Z; Cormack JB; Mendelson EB; Berg WA
Radiology; 2013 Dec; 269(3):701-12. PubMed ID: 23962417
[TBL] [Abstract][Full Text] [Related]
18. [Diagnostic value of a breast MRI score for the prediction of malignancy of breast lesions detected solely with MRI].
Siegmann KC; Moron HU; Baur A; Hahn M; Vogel U; Claussen CD; Bitzer M
Rofo; 2009 Jun; 181(6):556-63. PubMed ID: 19452398
[TBL] [Abstract][Full Text] [Related]
19. Characteristics, Malignancy Rate, and Follow-up of BI-RADS Category 3 Lesions Identified at Breast MR Imaging: Implications for MR Image Interpretation and Management.
Chikarmane SA; Birdwell RL; Poole PS; Sippo DA; Giess CS
Radiology; 2016 Sep; 280(3):707-15. PubMed ID: 27089027
[TBL] [Abstract][Full Text] [Related]
20. Role of magnetic resonance imaging in probably benign (BI-RADS category 3) microcalcifications of the breast.
Linda A; Zuiani C; Londero V; Di Gaetano E; Dal Col A; Girometti R; Bazzocchi M
Radiol Med; 2014 Jun; 119(6):393-9. PubMed ID: 24297595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
